Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120) (SL120)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Alzheimer's Association
Information provided by (Responsible Party):
Suzanne Craft, Wake Forest School of Medicine
ClinicalTrials.gov Identifier:
NCT01595646
First received: May 8, 2012
Last updated: November 30, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)